Perkinelmer Health Sciences Inc. Sustainability Profile
PerkinElmer Health Sciences Inc., a prominent player in the life sciences and diagnostics industry, is headquartered in the United States. Founded in 1937, the company has established itself as a leader in providing innovative solutions for health and environmental testing. With a strong presence in North America, Europe, and Asia, PerkinElmer focuses on areas such as genetic testing, drug discovery, and environmental monitoring. The company offers a diverse range of core products and services, including advanced analytical instruments, reagents, and software solutions that enhance laboratory efficiency and accuracy. PerkinElmer's commitment to innovation has led to significant milestones, including breakthroughs in newborn screening and molecular diagnostics. Recognised for its market leadership, PerkinElmer continues to drive advancements in health sciences, making a substantial impact on global health outcomes.
DitchCarbon Score
How does Perkinelmer Health Sciences Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Perkinelmer Health Sciences Inc.'s score of 46 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Perkinelmer Health Sciences Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Revvity, Inc., any emissions data or climate commitments would be inherited from this parent organisation. Perkinelmer has not publicly disclosed any reduction targets or significant climate initiatives at this time. The absence of specific emissions figures and reduction commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As part of the corporate family relationship with Revvity, Inc., any future climate commitments or emissions data may be aligned with the initiatives and targets set by Revvity. This could include participation in frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), although specific details on these initiatives have not been provided. In summary, while Perkinelmer Health Sciences Inc. currently lacks detailed emissions data and reduction targets, its climate commitments may evolve in alignment with its parent company, Revvity, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,289,000 | 0,000,000 |
| Scope 2 | 29,844,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Perkinelmer Health Sciences Inc.'s Industry?
How Carbon Intensive is Perkinelmer Health Sciences Inc.'s Location?
Perkinelmer Health Sciences Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Perkinelmer Health Sciences Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
